Anixa Biosciences and Moffitt Cancer Center Advance Ovarian Cancer CAR-T Clinical Trial to Highest Dose Level to Date
Go back to Anixa Biosciences and Moffitt Cancer Center Advance Ovarian Cancer CAR-T Clinical Trial to Highest Dose Level to Date| (NASDAQ: ANIX) | Delayed: 2.84 +0.08 (2.90%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.76 | 52 Week High | $ | |||
| Open | $2.79 | 52 Week Low | $ | |||
| Day High | $2.88 | P/E | N/A | |||
| Day Low | $2.76 | EPS | $ | |||
| Volume | 209,828 | |||||

